\BOOKMARK [0][-]{chapter.1}{Introduction}{}% 1
\BOOKMARK [0][-]{chapter.2}{Physical Principles}{}% 2
\BOOKMARK [1][-]{section.2.1}{Interaction of Photons and Electrons in Matter}{chapter.2}% 3
\BOOKMARK [2][-]{subsection.2.1.1}{Photoelectric Effect}{section.2.1}% 4
\BOOKMARK [2][-]{subsection.2.1.2}{Compton Scattering}{section.2.1}% 5
\BOOKMARK [2][-]{subsection.2.1.3}{Pair Production}{section.2.1}% 6
\BOOKMARK [2][-]{subsection.2.1.4}{Combined Cross Section for Photons in Matter}{section.2.1}% 7
\BOOKMARK [2][-]{subsection.2.1.5}{Interaction of Charged Particles with Matter}{section.2.1}% 8
\BOOKMARK [1][-]{section.2.2}{Radiation Biology}{chapter.2}% 9
\BOOKMARK [2][-]{subsection.2.2.1}{DNA Radiation Damage}{section.2.2}% 10
\BOOKMARK [2][-]{subsection.2.2.2}{The Linear-Quadratic Model}{section.2.2}% 11
\BOOKMARK [2][-]{subsection.2.2.3}{Oxygen Effect}{section.2.2}% 12
\BOOKMARK [2][-]{subsection.2.2.4}{Origin of Hypoxia in Tumours}{section.2.2}% 13
\BOOKMARK [2][-]{subsection.2.2.5}{Impact of Hypoxia on Cell Survival}{section.2.2}% 14
\BOOKMARK [1][-]{section.2.3}{Treatment Planning}{chapter.2}% 15
\BOOKMARK [2][-]{subsection.2.3.1}{Dose Delivery with IMRT}{section.2.3}% 16
\BOOKMARK [2][-]{subsection.2.3.2}{Treatment Planning with KonRad}{section.2.3}% 17
\BOOKMARK [2][-]{subsection.2.3.3}{Physical Objective Function}{section.2.3}% 18
\BOOKMARK [2][-]{subsection.2.3.4}{Dose Calculation \046 Biological Effect}{section.2.3}% 19
\BOOKMARK [2][-]{subsection.2.3.5}{Biological Objective Function}{section.2.3}% 20
\BOOKMARK [0][-]{chapter.3}{Dose Painting Methods}{}% 21
\BOOKMARK [1][-]{section.3.1}{PET Imaging}{chapter.3}% 22
\BOOKMARK [2][-]{subsection.3.1.1}{ Decay}{section.3.1}% 23
\BOOKMARK [2][-]{subsection.3.1.2}{Physical Principle of PET}{section.3.1}% 24
\BOOKMARK [1][-]{section.3.2}{Quantification of Hypoxia}{chapter.3}% 25
\BOOKMARK [2][-]{subsection.3.2.1}{Radiopharmaceutical Approach to Hypoxia Assessment}{section.3.2}% 26
\BOOKMARK [2][-]{subsection.3.2.2}{Modelling Hypoxia with FMISO}{section.3.2}% 27
\BOOKMARK [2][-]{subsection.3.2.3}{Correlation of Tumour Hypoxia vs. FMISO Uptake Values}{section.3.2}% 28
\BOOKMARK [2][-]{subsection.3.2.4}{Eppendorf Polarographic Needle Electrodes}{section.3.2}% 29
\BOOKMARK [2][-]{subsection.3.2.5}{Other Methods for Assessing Hypoxia}{section.3.2}% 30
\BOOKMARK [1][-]{section.3.3}{Review of Dose Painting Methods}{chapter.3}% 31
\BOOKMARK [2][-]{subsection.3.3.1}{Binary Dose Escalation}{section.3.3}% 32
\BOOKMARK [2][-]{subsection.3.3.2}{Functional Dose Escalation}{section.3.3}% 33
\BOOKMARK [2][-]{subsection.3.3.3}{Dose Painting by Numbers via Kinetic Models}{section.3.3}% 34
\BOOKMARK [2][-]{subsection.3.3.4}{Dose Redistribution}{section.3.3}% 35
\BOOKMARK [1][-]{section.3.4}{Novel Approach: Biological Dose Painting}{chapter.3}% 36
\BOOKMARK [2][-]{subsection.3.4.1}{Implementation of Biological Dose Painting in KonRad}{section.3.4}% 37
\BOOKMARK [2][-]{subsection.3.4.2}{Clinical Tumour Hypoxia}{section.3.4}% 38
\BOOKMARK [2][-]{subsection.3.4.3}{PET Imaging}{section.3.4}% 39
\BOOKMARK [1][-]{section.3.5}{Implementation of Biological Dose Painting}{chapter.3}% 40
\BOOKMARK [2][-]{subsection.3.5.1}{Creation of Realistic Artificial PET Images}{section.3.5}% 41
\BOOKMARK [2][-]{subsection.3.5.2}{Plan Comparison}{section.3.5}% 42
\BOOKMARK [0][-]{chapter.4}{Feasibility of Biological Dose Painting}{}% 43
\BOOKMARK [1][-]{section.4.1}{Patients}{chapter.4}% 44
\BOOKMARK [1][-]{section.4.2}{Application of Biological Dose Painting}{chapter.4}% 45
\BOOKMARK [1][-]{section.4.3}{Results}{chapter.4}% 46
\BOOKMARK [2][-]{subsection.4.3.1}{Impact of Hypoxia Sub Volumes in GTV}{section.4.3}% 47
\BOOKMARK [2][-]{subsection.4.3.2}{Delivery Quality and Feasibility of Dose Painting}{section.4.3}% 48
\BOOKMARK [2][-]{subsection.4.3.3}{Nominal Plan vs Biological Dose Painting}{section.4.3}% 49
\BOOKMARK [1][-]{section.4.4}{Discussion}{chapter.4}% 50
\BOOKMARK [2][-]{subsection.4.4.1}{Feasibility of Biological Dose Painting}{section.4.4}% 51
\BOOKMARK [2][-]{subsection.4.4.2}{High Dose Fractions}{section.4.4}% 52
\BOOKMARK [2][-]{subsection.4.4.3}{Size of Hypoxic Volumes}{section.4.4}% 53
\BOOKMARK [1][-]{section.4.5}{Conclusion}{chapter.4}% 54
\BOOKMARK [0][-]{chapter.5}{Analysis of model parameter uncertainties}{}% 55
\BOOKMARK [1][-]{section.5.1}{Model Parameter Uncertainties}{chapter.5}% 56
\BOOKMARK [2][-]{subsection.5.1.1}{pO2 Model}{section.5.1}% 57
\BOOKMARK [2][-]{subsection.5.1.2}{Hypoxia Reduction Factors}{section.5.1}% 58
\BOOKMARK [1][-]{section.5.2}{Results}{chapter.5}% 59
\BOOKMARK [1][-]{section.5.3}{Discussion}{chapter.5}% 60
\BOOKMARK [1][-]{section.5.4}{Conclusion}{chapter.5}% 61
\BOOKMARK [0][-]{chapter.6}{Outlook: Improving Biological Dose Painting}{}% 62
\BOOKMARK [1][-]{section.6.1}{Understanding PET Images}{chapter.6}% 63
\BOOKMARK [2][-]{subsection.6.1.1}{Accuracy of PET Images}{section.6.1}% 64
\BOOKMARK [2][-]{subsection.6.1.2}{Temporal Variance}{section.6.1}% 65
\BOOKMARK [2][-]{subsection.6.1.3}{Reoxygenation \046 Single Image Planning}{section.6.1}% 66
\BOOKMARK [1][-]{section.6.2}{Interpretation of Hypoxia}{chapter.6}% 67
\BOOKMARK [0][-]{chapter.7}{Summary \046 Conclusions}{}% 68
\BOOKMARK [0][-]{appendix.A}{Dose compensation for hypoxia}{}% 69
\BOOKMARK [0][-]{appendix.B}{Patient statistics}{}% 70
\BOOKMARK [0][-]{section*.53}{Bibliography}{}% 71
